REG - Morgan Stanley Cap - Rule 38.5 - ABBVIE INC.

Morgan StanleyAnnouncement

17/03/2020 12:15

RNS Number : 4465G
  
Morgan Stanley Capital Services LLC
  
17 March 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION



 Name of exempt market-maker


   Morgan Stanley Capital Services LLC




 Company dealt in


   ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


   16 MARCH 2020



 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales



 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  96,390


 81.9900 USD


 73.6700 USD



 



 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  57,070


 81.7800 USD


 73.6500 USD



 
 
(b)           Derivatives transactions (other than options transactions)
 



 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 CFD


 LONG


 2,783


 73.8382 USD




 CFD


 LONG


 6,188


 74.2700 USD




 CFD


 LONG


 672


 74.2700 USD




 CFD


 LONG


 45


 74.6051 USD




 CFD


 LONG


 100


 76.3401 USD




 CFD


 LONG


 1,299


 76.3464 USD




 CFD


 LONG


 433


 76.9850 USD




 CFD


 LONG


 100


 77.0878 USD




 CFD


 LONG


 600


 77.0878 USD




 CFD


 LONG


 2,200


 77.0878 USD




 CFD


 LONG


 1,200


 77.0878 USD




 CFD


 LONG


 700


 77.0878 USD




 CFD


 LONG


 7,361


 77.1548 USD




 CFD


 LONG


 40


 77.1600 USD




 CFD


 LONG


 197


 77.8965 USD




 CFD


 LONG


 8,463


 77.8965 USD




 CFD


 LONG


 521


 78.7145 USD




 CFD


 LONG


 79


 78.7145 USD




 CFD


 LONG


 3


 78.8600 USD




 CFD


 LONG


 197


 79.4979 USD




 CFD


 LONG


 8,463


 79.4979 USD




 CFD


 LONG


 881


 80.3601 USD




 CFD


 LONG


 400


 81.7491 USD




 CFD


 SHORT


 20


 74.2700 USD




 CFD


 SHORT


 65


 74.2700 USD




 CFD


 SHORT


 3,421


 74.8673 USD




 CFD


 SHORT


 8,971


 75.5343 USD




 CFD


 SHORT


 47,815


 76.9453 USD




 CFD


 SHORT


 4,700


 77.0201 USD




 CFD


 SHORT


 35


 77.3400 USD




 CFD


 SHORT


 3,681


 77.5248 USD




 CFD


 SHORT


 5


 80.1300 USD




 CFD


 SHORT


 9,500


 80.3499 USD




 CFD


 SHORT


 1,500


 80.6786 USD



 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 



 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A 



 
(ii) Exercising
 



 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  



 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 



Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 



 
 



 Date of disclosure


 17 MARCH 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEUBRARRWUOAAR